Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SUMO2 Antikörper

Der Maus Monoklonal Anti-SUMO2-Antikörper wurde für WB, IHC, IF, FACS und StM validiert. Er ist geeignet, SUMO2 in Proben von Human zu detektieren.
Produktnummer ABIN6940601

Kurzübersicht für SUMO2 Antikörper (ABIN6940601)

Target

Alle SUMO2 Antikörper anzeigen
SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

Reaktivität

  • 104
  • 40
  • 36
  • 3
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 83
  • 25
  • 1
Maus

Klonalität

  • 84
  • 26
Monoklonal

Konjugat

  • 59
  • 10
  • 8
  • 7
  • 5
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser SUMO2 Antikörper ist unkonjugiert

Applikation

  • 73
  • 54
  • 39
  • 21
  • 13
  • 11
  • 11
  • 9
  • 7
  • 6
  • 4
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Staining Methods (StM)

Klon

SM23-496
  • Spezifität

    This MAb reacts with both SUMO-2 and SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer's disease.

    Kreuzreaktivität (Details)

    Predicted to show a broad species reactivity.

    Aufreinigung

    Purified by Protein A/G

    Immunogen

    Recombinant human SUMO2 protein

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Positive Control: MCF-7, HepG2, HeLa cells. Breast carcinoma.

    Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

    Andere Bezeichnung

    SUMO2 & SUMO3

    Molekulargewicht

    11-13kDa

    Gen-ID

    6613, 6612

    UniProt

    P61956, P55854

    Pathways

    Methionine Biosynthetic Process
Sie sind hier:
Chat with us!